CSBR:NASDAQ
Champions Oncology Inc
USD 4,68
arrow_downward
-0,53%(-0,025) 1D
16 Nov., 16:00:00 GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CSBR...
Open
USD 4,68
High
USD 4,68
Low
USD 4,68
Mkt. cap
65,07 m
Avg. vol.
8,15 k
Volume
0,00
52-wk high
USD 8,31
52-wk low
USD 4,52
EPS
-USD 0,08
Beta
0,47
Shares outstanding
13,92 m
No. of employees
217
Open
USD 4,68
High
USD 4,68
Low
USD 4,68
Mkt. cap
65,07 m
Avg. vol.
8,15 k
Volume
0,00
52-wk high
USD 8,31
52-wk low
USD 4,52
EPS
-USD 0,08
Beta
0,47
Shares outstanding
13,92 m
No. of employees
217
News stories
From web sources and news partners
Investor's Business Daily
·
15 minute gelede
Analysts Expect 4 S&P 500 Stocks To Outgrow Nvidia Next Year
Benzinga
·
30 minute gelede
Shipping Stocks Rose 4.5% Last Week, Outperforming S&P 500; United Maritime Led Gains
Quartz
·
24 minute gelede
The Dow fell more than 700 points on Monday and the S&P 500 lost 1.9%
The Motley Fool
·
1 uur gelede
Will Your S&P 500 Index Fund Be Forced to Buy Anthropic? Here’s What the Rules Say.
Profile
Champions Oncology is an American technology company that develops mouse avatars. Called TumorGrafts, they are used to test a panel of chemotherapy regimens, targeted therapies and monoclonal antibodies to identify potential therapeutic options for cancer patients. The company was founded in 2007 by David Sidransky, M.D., a Johns Hopkins University oncologist. Wikipedia
About Champions Oncology Inc
CEO-
Employees217
Founded2007
HeadquartersHackensack, New Jersey, Verenigde State van Amerika
SectorHealth Care
Industry-
Websitechampionsoncology.com